Savant Capital LLC Decreases Holdings in Cardinal Health, Inc. (NYSE:CAH)

Savant Capital LLC trimmed its holdings in Cardinal Health, Inc. (NYSE:CAH) by 7.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 36,940 shares of the company’s stock after selling 2,799 shares during the quarter. Savant Capital LLC’s holdings in Cardinal Health were worth $4,369,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of CAH. Angeles Wealth Management LLC acquired a new stake in Cardinal Health during the fourth quarter worth about $205,000. Kestra Private Wealth Services LLC increased its position in Cardinal Health by 23.7% during the fourth quarter. Kestra Private Wealth Services LLC now owns 16,593 shares of the company’s stock worth $1,962,000 after purchasing an additional 3,177 shares during the last quarter. Miller Howard Investments Inc. NY acquired a new stake in Cardinal Health during the fourth quarter worth about $573,000. Entropy Technologies LP purchased a new position in Cardinal Health during the fourth quarter worth about $1,596,000. Finally, Wilmington Savings Fund Society FSB boosted its stake in Cardinal Health by 2.8% during the fourth quarter. Wilmington Savings Fund Society FSB now owns 7,870 shares of the company’s stock worth $931,000 after buying an additional 211 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CAH has been the subject of several research analyst reports. UBS Group increased their target price on shares of Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $132.00 to $145.00 in a report on Monday, January 6th. Citigroup raised their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research report on Friday, January 10th. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. lifted their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Four investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $136.87.

Cardinal Health Trading Up 0.9 %

Cardinal Health stock opened at $128.38 on Wednesday. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $132.84. The stock has a market cap of $31.01 billion, a P/E ratio of 23.95, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63. The company has a fifty day simple moving average of $122.66 and a 200-day simple moving average of $115.83.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.58%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is 37.69%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.